Sen. Cory Booker Calls For More Transparency In Medicaid Drug Decisions

The "Medicaid Drug Decisions Transparency Act" would require pharmaceutical companies to disclose their payments to pharmacists and others who serve on state Medicaid drug boards — the advisory groups that decide which drugs Medicaid will and won

Booker is introducing a bill this week in response to an investigation by the Center for Public Interest and NPR. He calls drug firms’ infiltration into Medicaid’s decision process “nefarious.”

(Image credit: Gary Waters/Ikon Images/Getty Images)

Read the full post on Health Care : NPR

Liz Whyte